GMT Data

Simcere Pharmaceutical Group Limited (02096)

DirectorsAuditors
DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Bao Jun10-Jun-2009-Nov-22CoSec
09-Nov-22J-CoSec, AuRep
09-Nov-22
Due to his personal career development
Feng Honggang09-Feb-24NED
Feng Jie10-Jun-2030-Jun-21CoSec
Mak Cherie Po Man17-Sep-2014-Jun-24CoSec
Mak Po Man Cherie25-Mar-26J-CoSec
Ren Jinsheng20-Aug-26CEO
Ren Jinsheng30-Nov-15Ch, Fdr
30-Nov-1525-Mar-26CEO
25-Mar-26
In order to focus on the formulation of the Group’s long-term strategies, major investment decisions and overseeing the discharge of the Board’s duties. Mr. Ren will continue to serve as the Chairman and executive Director.
Song Rui Lin19-Nov-19INED
Sung Ka Woon18-Jan-23INED
Tang Renhong20-Aug-26Non-executive Director
Tang Renhong31-Dec-2220-Aug-26ED
20-Aug-26
Re-designated from an executive Director to a non-executive Director in light of the proposed spin-off and separate listing of Simcere Zaiming Pharmaceutical Co., Ltd. on the Main Board of The Stock Exchange of Hong Kong Limited.
25-May-2231-Dec-22Co-CEO
31-Dec-22Co-chief Executive Officer (Co-CEO)
30-Dec-22
Due to work rearrangement. Appointed by the Group as the chairman of the board of directors and chief executive officer of Simcere Zaiming Pharmaceutical Co., Ltd.
19-Nov-1925-May-22ED, SVP
Wan Yushan09-Nov-22CoSec
19-Nov-19FD
20-Aug-26J-CoSec
20-Aug-26
Ceased to act in role. Mr. WAN will remain as an executive Director and the chief financial officer.
Wang Jianguo19-Nov-19INED
Wang Xi18-Jan-23ED
Wang Xinhua19-Nov-19INED
Wong Wai Ling14-Jun-24CoSec
14-Jun-2425-Mar-26J-CoSec
25-Mar-26
Resignation.
Zhang Cheng19-Nov-1931-Mar-21COO, ED
Zhang Yi01-Jun-20NED
Zhao John Huan19-Nov-1931-Aug-22NED
31-Aug-22
In order to devote more time to focus on his other business commitments
Zhou Yunshu25-Mar-2620-Aug-26CEO
20-Aug-26
In order to further accelerate the development of our business in China and strengthen our global innovation capabilities, upon Dr. Zhou’s recommendation and with the Board’s approval, Mr. Ren will serve as the Chief Executive Officer.
Zhu Da20-Aug-26J-CoSec